Michiel Thomeer

7.9k total citations · 2 hit papers
75 papers, 4.6k citations indexed

About

Michiel Thomeer is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Michiel Thomeer has authored 75 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Michiel Thomeer's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers), Sarcoidosis and Beryllium Toxicity Research (11 papers) and Metabolomics and Mass Spectrometry Studies (10 papers). Michiel Thomeer is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers), Sarcoidosis and Beryllium Toxicity Research (11 papers) and Metabolomics and Mass Spectrometry Studies (10 papers). Michiel Thomeer collaborates with scholars based in Belgium, Netherlands and United States. Michiel Thomeer's co-authors include Ulrich Costabel, Benoît Nemery, Abderrahim Nemmar, L. Mortelmans, Peter Hoet, H Vanbilloen, Marc Hoylaerts, David Dinsdale, Roland M. du Bois and Paul W. Noble and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Michiel Thomeer

70 papers receiving 4.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Passage of Inhaled Particles Into the Blood Circulation in Humans

2002 1.3k citations Michiel Thomeer et al. profile →
Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important Difference

2011 356 citations Roland M. du Bois, Derek Weycker et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michiel Thomeer Belgium	25	2.7k	1.1k	921	511	344	75	4.6k
Ware G. Kuschner United States	27	2.0k 0.7×	491 0.5×	609 0.7×	201 0.4×	271 0.8×	88	3.9k
An‐Soo Jang South Korea	34	1.6k 0.6×	1.5k 1.4×	661 0.7×	618 1.2×	195 0.6×	190	3.8k
Bruce E. Lehnert United States	36	2.1k 0.8×	511 0.5×	854 0.9×	1.6k 3.1×	568 1.7×	121	5.8k
Kevin E. Driscoll United States	37	2.0k 0.7×	357 0.3×	2.0k 2.2×	639 1.3×	231 0.7×	87	4.9k
Thomas P. Kennedy United States	41	1.4k 0.5×	879 0.8×	384 0.4×	1.2k 2.4×	165 0.5×	102	5.3k
David W. Kamp United States	46	3.2k 1.2×	326 0.3×	1.1k 1.2×	1.9k 3.6×	345 1.0×	96	6.3k
Carl J. Johnston United States	36	1.7k 0.6×	218 0.2×	695 0.8×	737 1.4×	454 1.3×	80	4.0k
George D. Leikauf United States	49	2.4k 0.9×	1.9k 1.7×	1.5k 1.6×	2.2k 4.4×	358 1.0×	143	7.4k
David Thickett United Kingdom	45	2.8k 1.0×	813 0.7×	241 0.3×	996 1.9×	414 1.2×	230	6.3k
Victor L. Roggli United States	47	6.1k 2.2×	412 0.4×	823 0.9×	562 1.1×	936 2.7×	239	8.0k

Countries citing papers authored by Michiel Thomeer

Since Specialization

Citations

This map shows the geographic impact of Michiel Thomeer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiel Thomeer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiel Thomeer more than expected).

Fields of papers citing papers by Michiel Thomeer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michiel Thomeer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiel Thomeer. The network helps show where Michiel Thomeer may publish in the future.

Co-authorship network of co-authors of Michiel Thomeer

This figure shows the co-authorship network connecting the top 25 collaborators of Michiel Thomeer. A scholar is included among the top collaborators of Michiel Thomeer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michiel Thomeer. Michiel Thomeer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Adriaensens, Peter, Maarten Criel, Evelyne Louis, et al.. (2024). Plasma Metabolite Profiling in the Search for Early-Stage Biomarkers for Lung Cancer: Some Important Breakthroughs. International Journal of Molecular Sciences. 25(9). 4690–4690. 1 indexed citations

Demeyer, Heleen, Maarten Criel, Marc Daenen, et al.. (2024). Prognostic value of the 1-min sit-to-stand test to predict post-operative complications in patients with lung cancer elected for lung resection. ERJ Open Research. 10(4). 765–2023. 2 indexed citations

Machado, Ana, Fabiano Francisco de Lima, Marc Daenen, et al.. (2023). Physical status, symptoms and health-related quality of life during a severe exacerbation of COPD: Recovery and discriminative capacity for future events. Respiratory Medicine. 220. 107437–107437. 2 indexed citations

Machado, Ana, Jana De Brandt, Marc Daenen, et al.. (2022). Impact of acute exacerbations of COPD on patients’ health status beyond pulmonary function: A scoping review. Pulmonology. 29(6). 518–534. 19 indexed citations

Poucke, Sven Van, Michiel Thomeer, John W. Heath, & Milan Vukičević. (2016). Are Randomized Controlled Trials the (G)old Standard? From Clinical Intelligence to Prescriptive Analytics. Journal of Medical Internet Research. 18(7). e185–e185. 34 indexed citations

Louis, Evelyne, Peter Adriaensens, Wanda Guedens, et al.. (2016). Detection of Lung Cancer through Metabolic Changes Measured in Blood Plasma. Journal of Thoracic Oncology. 11(4). 516–523. 59 indexed citations

Pujol, Jean-Louis, Johan Vansteenkiste, Tommaso Martino De Pas, et al.. (2015). Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology. 10(10). 1458–1467. 51 indexed citations

Kreuter, Michael, Johan Vansteenkiste, J.R. Fischer, et al.. (2012). Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study. Annals of Oncology. 24(4). 986–992. 56 indexed citations

Bois, Roland M. du, Derek Weycker, Carlo Albera, et al.. (2011). Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important Difference. American Journal of Respiratory and Critical Care Medicine. 184(12). 1382–1389. 356 indexed citations breakdown →

10.

Bois, Roland M. du, Derek Weycker, Carlo Albera, et al.. (2011). Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 184(4). 459–466. 297 indexed citations

11.

Bois, Roland M. du, Derek Weycker, Carlo Albera, et al.. (2010). Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis: Test Validation and Minimal Clinically Important Difference. American Journal of Respiratory and Critical Care Medicine. 183(9). 1231–1237. 330 indexed citations

12.

Wallemacq, Pierre, et al.. (2009). Viscerale leishmaniasis met hemofagocytaire lymfohistiocytose: casus en literatuuroverzicht. Tijdschrift voor Geneeskunde. 570–574. 1 indexed citations

13.

Raghu, Ganesh, Kevin M. Brown, Ulrich Costabel, et al.. (2008). Treatment of Idiopathic Pulmonary Fibrosis with Etanercept: An Exploratory, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine. 178(9). 948–955. 264 indexed citations

14.

Bois, Roland M. du, Carlo Albera, Ulrich Costabel, et al.. (2008). CATEGORICAL DECLINES IN PERCENT PREDICTED FORCED VITAL CAPACITY (PP-FVC) ARE ASSOCIATED WITH A GRADED RISK OF DEATH IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF). CHEST Journal. 134(4). 20S–20S. 2 indexed citations

15.

Thomeer, Michiel, Maurits Demedts, Jürgen Behr, et al.. (2007). Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. European Respiratory Journal. 31(3). 585–591. 99 indexed citations

16.

Raghu, Ganesh, Joseph A. Lasky, Ulrich Costabel, et al.. (2005). A RANDOMIZED PLACEBO CONTROLLED TRIAL ASSESSING THE EFFICACY AND SAFETY OF ETANERCEPT IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF). CHEST Journal. 128(4). 496S–496S. 14 indexed citations

17.

Thomeer, Michiel, Johan Vansteenkiste, Eric Verbeken, & Maurits Demedts. (2004). Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment. Respiratory Medicine. 98(6). 567–573. 42 indexed citations

18.

Kiss, Gabriel, Johan Van Cleynenbreugel, Michiel Thomeer, Paul Suetens, & Guy Marchal. (2001). Computer aided diagnosis for virtual colonography. Lecture notes in computer science. 2208. 621–628. 2 indexed citations

19.

Thomeer, Michiel, Dirk Vanbeckevoort, Carine Petré, et al.. (2000). Appendicitis after appendectomy: CT diagnosis. European Radiology. 10(4). 674–676.

20.

Thomeer, Michiel, et al.. (1999). Systemic lupus erythematosus, eosinophilia and Löffler′s endocarditis. An unusual association. European Respiratory Journal. 13(4). 930–930. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact